Northwest Biotherapeutics, Inc. · OTC:NWBO

Northwest Biotherapeutics, Inc. financial statements

Northwest Biotherapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.38M1.38M1.93M1.68M1.00M1.29M2.41M412.0K336.0K623.0K
Research and development28.8M34.9M27.7M35.5M20.3M33.6M14.1M18.2M33.5M60.1M
Operating income-59.9M-66.5M-55.5M-67.2M-52.7M-86.6M-28.0M-41.5M-54.7M-79.3M
Depreciation and amortization2.06M1.74M1.52M1.25M324.0K87.0K21.0K1.29M439.0K189.0K
EBITDA-57.9M-64.8M-54.0M-65.9M-52.4M-86.5M-28.0M-40.2M-54.2M-79.1M
Interest expense8.70M7.77M5.24M6.07M5.01M8.54M2.98M9.87M5.54M3.82M
Income before tax-60.7M-83.8M
Income tax-537.0K000000000
Net income-60.2M-83.8M-62.6M-105.0M179.1M-529.8M-20.8M-35.8M-73.1M-80.2M
Earnings per share, basic-0.04-0.07-0.06-0.100.21-0.73-0.04-0.12-0.31-0.77
Earnings per share, diluted-0.04-0.07-0.06-0.10-0.06-0.73-0.04-0.12-0.31-0.77

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents3.04M2.17M2.13M6.96M15.2M9.98M372.0K22.2M117.0K6.87M
Current assets5.52M4.06M4.13M9.43M17.3M15.5M3.20M23.8M1.40M7.88M
Property, plant and equipment17.4M16.2M17.3M13.4M15.0M1.04M281.0K108.0K47.5M315.0K
Goodwill626.0K626.0K626.0K626.0K626.0K626.0K0
Total assets81.3M26.7M27.9M31.3M40.2M32.9M10.6M24.7M48.9M52.9M
Accounts payable12.4M
Current liabilities91.7M68.3M45.2M126.0M133.8M382.4M44.2M69.8M87.7M76.4M
Total debt60.0M62.7M40.8M21.5M32.4M14.8M12.7M16.8M31.4M31.7M
Total liabilities128.9M105.7M74.9M136.4M164.2M395.8M55.7M71.8M96.2M79.4M
Shareholders' equity-60.3M-94.5M-65.8M-128.1M-124.0M-362.9M-45.1M-48.1M-67.3M-26.5M
Shares outstanding1.56B1.33B1.18B1.07B948.4M829.6M614.3M523.2M328.9M157.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-44.8M-57.0M-53.6M-52.8M-38.3M-32.1M-31.9M-34.6M-36.5M-55.7M
Capital spending-1.50M-1.01M-171.0K
Free cash flow-46.3M-58.0M-32.0M
Cash from investing-1.81M-1.01M-3.44M-2.90M-6.01M-8.14M-360.0K45.4M212.0K-4.94M
Cash from financing49.3M56.8M52.8M42.0M48.1M52.7M9.95M7.87M34.3M38.3M
Change in cash865.0K49.0K-4.84M-8.20M5.19M9.61M-21.9M22.1M-6.75M-16.2M